StructureDefinition-ClinicalUseDefinition-interaction-uv-epi

Sourcehl7.fhir.uv.vulcan-eproduct-info#current:Electronic Medicinal Product Information (ePI) FHIR Implementation Guide (v5.0.0-ballot)
resourceTypeStructureDefinition
idClinicalUseDefinition-interaction-uv-epi
canonicalhttp://hl7.org/fhir/uv/vulcan-eproduct-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi
version1.0.0-Ballot
statusactive
nameClinicalUseDefinitionInteractionUvEpi
titleClinicalUseDefinition Interaction (ePI)
date2022-11-29T00:09:20+00:00
descriptionClinicalUseDefinition Interaction (ePI)
jurisdictionsuv
fhirVersion5.0.0-ballot
kindresource
abstractfalse
sdTtypeClinicalUseDefinition
derivationconstraint
basehttp://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition
Usages
Name Flags Card. Type Description & Constraints doco
. . ClinicalUseDefinition ClinicalUseDefinition
. . . identifier Business identifier for this clinical use.
. . . type Required Pattern: interaction
. . . subject 1.. Reference (MedicinalProductDefinition (ePI))
. . . status Defines whether this clinical use is draft, active or retired
. . . contraindication .. 0
. . . indication .. 0
. . . interaction
. . . . interactant
. . . . . itemCodeableConcept 0..1 CodeableConcept Binding: WHO ATC ( preferred ): The specific substance that interacts.

Additional Bindings Purpose
Substances conformance
. . . . type The type of the interaction e.g. drug-drug, drug-food, drug-lab.
. . . undesirableEffect .. 0
. . . warning .. 0

doco Documentation for this format

Produced 06 Apr 2023